Advanced search
Publication Cover
The Journal of Maternal-Fetal & Neonatal Medicine Volume 23, 2010 - Issue 10
Submit an article Journal homepage
241
Views
23
CrossRef citations to date
0
Altmetric
Original Article

Obstetrician–gynaecologist knowledge of and access to information about the risks of medication use during pregnancy

Maria A. MorganAmerican College of Obstetricians and Gynecologists, Washington, DC, USA
,
Janet D. CraganNational Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA
,
Robert L. GoldenbergDrexel University College of Medicine, Philadelphia, PA, USA
,
Sonja A. RasmussenNational Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA
&
Jay SchulkinAmerican College of Obstetricians and Gynecologists, Washington, DC, USACorrespondence[email protected]
Pages 1143-1150 | Received 23 Sep 2009, Accepted 14 Jan 2010, Published online: 10 Mar 2010

References

  • Finer LB, Henshaw SK. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health 2006;38:90–96.
  • Henshaw SK. Unintended pregnancy in the United States. Fam Plann Perspect 1998;30:24–29.
  • Lo WY, Friedman JM. Teratogenicity of recently introduced medications in human pregnancy. Obstet Gynecol 2002;100:465–473.
  • Mitchell AA, editor. Special considerations in studies of drug-induced birth defects. Hoboken, NJ: John Wiley & Sons; 2000.
  • Andrade SE, Gurwitz JH, Davis RL, Chan KA, Finkelstein JA, Fortman K, McPhillips H, Raebel MA, Roblin D, Smith DH, et al Prescription drug use in pregnancy. Am J Obstet Gynecol 2004;191:398–407.
  • US Food and Drug Administration Center for Drug Evaluation and Research. Guidance for Industry. Establishing Pregnancy Exposure Registries. Internet. 2002. Electronic Citation. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM071639.pdf. Last accessed June 2009.
  • Schwarz EB, Maselli J, Norton M, Gonzales R. Prescription of teratogenic medications in United States ambulatory practices. Am J Med 2005;118:1240–1249.
  • Werler MM, Mitchell AA, Hernandez-Diaz S, Honein MA. Use of over-the-counter medications during pregnancy. Am J Obstet Gynecol 2005;193:771–777.
  • Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation: a reference guide to fetal and neonatal risk. 8th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008.
  • Moretti ME, Maxson A, Hanna F, Koren G. Evaluating the safety of St. John's Wort in human pregnancy. Reprod Toxicol 2009;28:96–99.
  • Physicians' Desk Reference 2009. Thomson Reuters. 63rd ed., Montvale, NJ, USA (November 30, 2008).
  • Fisher B, Rose NC, Carey JC. Principles and practice of teratology for the obstetrician. Clin Obstet Gynecol 2008;51:106–118.
  • Refuerzo JS, Blackwell SC, Sokol RJ, Lajeunesse L, Firchau K, Kruger M, Sorokin Y. Use of over-the-counter medications and herbal remedies in pregnancy. Am J Perinatol 2005;22:321–324.
  • Glover DD, Amonkar M, Rybeck BF, Tracy TS. Prescription, over-the-counter, and herbal medicine use in a rural, obstetric population. Am J Obstet Gynecol 2003;188:1039–1045.
  • Lapi F, Vannacci A, Moschini M, Cipollini F, Morsuillo M, Gallo E, Banchelli G, Cecchi E, Pirro MD, Giovannini MG, et al Use, attitudes and knowledge of complementary and alternative drugs (CADs) among pregnant women: a preliminary survey in Tuscany. Evid Based Complement Alternat Med, May 7 eCAM 2008. DOI:10.1093/ecam/nen031.
  • Li DK, Liu L, Odouli R. Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. BMJ 2003;327:368–372.
  • Friedman JM. Teratology society: presentation to the FDA public meeting on safety issues associated with the use of dietary supplements during pregnancy. Teratology 2000;62:134–137.
  • Marcus DM, Snodgrass WR. Do no harm: avoidance of herbal medicines during pregnancy. Obstet Gynecol 2005;105(5 Pt 1):1119–1122.
  • Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs 2001;61:2163–2175.
  • Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 2002;287:337–344.
  • Doering PL, Boothby LA, Cheok M. Review of pregnancy labeling of prescription drugs-is the current system adequate to inform of risks? Am J Obstet Gynecol 2002;187:333–339.
  • Public Affairs Committee of the Teratology Society. Teratology Public Affairs Committee position paper: pregnancy labeling for prescription drugs: ten years later. Birth Defects Res (Part A) 2007;79:627–630.
  • Ahn HK, Choi JS, Han JY, Kim MH, Chung JH, Ryu HM, Kim MY, Yang JH, Koong MK, Nava-Ocampo AA, et al Pregnancy outcome after exposure to oral contraceptives during the periconceptional period. Hum Exp Toxicol 2008;27:307–313.
  • Jellesen R, Strandberg-Larsen K, Jørgensen T, Olsen J, Thulstrup AM, Andersen AM. Maternal use of oral contraceptives and risk of fetal death. Paediatr Perinat Epidemiol 2008;22:334–340.
  • Feibus KB. FDA's proposed rule for pregnancy and lactation labeling: improving maternal child health through well-informed medicine use. J Med Toxicol 2008;4:284–288.
  • FDA web page listing registries to the references Internet. 2009. Electronic Citation. http://www.fda.gov/ScienceResearch/SpecialTopics/WomensHealthResearch/ucm134848.htm). Last accessed February 2010.
  • Morgan MA, Crall J, Goldenberg RL, Schulkin J. Oral health during pregnancy. J Matern Fetal Neonatal Med 2009;22:733–739.
  • Driscoll DA, Morgan MA, Schulkin J. Screening for Down syndrome: changing practice of obstetricians. Am J Obstet Gynecol 2009;200:459 e1–459 e9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.